PHARMACYCLICS, INC. (NASDAQ:PCYC)

Biotechnology word cloud

SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks

The firms we cover on Wall Street are sometimes like covering the major sports teams. Analysts are like the top players and tend to move around as their career strengths ...
Read Full Story »
Biotechnology word cloud

4 Top Biotechs Expected to Beat Earnings Expectations

With earning season just starting to be in full gear, everybody on Wall Street is looking for the earnings angle, and it seems like almost every firm we cover here ...
Read Full Story »
95992888

Large Cap Biotech Stocks to Buy Leading the Comeback Rally

After two years of dominant performance in 2012 and 2013, the biotech rally hit a wall in late February, and the top stocks got absolutely hammered. Immediately, the bears jumped ...
Read Full Story »
health care

Analyst Cancer and Biotech Stock Picks From ASCO

As the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty pharmaceutical companies making announcements and presenting clinical data. The biggest ...
Read Full Story »
Biotechnology word cloud

Who Bucked the Short Interest Trend in Biotech Stocks?

24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. Many biotech stocks pulled back in late March, and short sellers moved in on many ...
Read Full Story »
pandora

Credit Suisse Sees These Six Stocks as Momentum Traps

Momentum stocks are the greatest things in the world when the market goes up like it did last year. There is always somebody willing to buy the stocks high under ...
Read Full Story »
Morgan Stanley logo

Morgan Stanley Starts Mixed Coverage on Top Biotech Stocks

Like many of its Wall Street peers, the brutal sell-off in the biotechnology space has Morgan Stanley taking a closer look at the top names. The firm initiated coverage of ...
Read Full Story »
Biotechnology word cloud

Short Sellers Find Renewed Interest in Biotech Stocks

24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. After retreating from many of these stocks in the previous two periods, short sellers returned ...
Read Full Story »
Biotechnology word cloud

Short Sellers Shy Away From Biotechs

24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. By and large, short sellers shied away from these stocks in late January. The largest ...
Read Full Story »
yoga

Ten Top Growth Stock Ideas for 2014 From Baird

Many of the top Wall Street firms released their top 2014 ideas in the month of December. This is the first full trading week of 2014, and many firms are ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Corning, Intel, Merck, Micron and More

A new earnings season has started, and stocks and bonds are dealing with a likely patch for the government shutdown and the debt ceiling. So which are the stocks to ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Baidu, Cubist, Whole Foods and More

Stocks have seen five days of selling, and investors are deciding which stocks are bargains and which ones will have more downside. 24/7 Wall St. reviews dozens of Wall Street ...
Read Full Story »
Bull and Bear

Top 10 Analyst Upgrades and Downgrades: Citrix, eBay, Intel, SanDisk and More

Investors and traders are usually on the lookout for new research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall ...
Read Full Story »
Money, US, $100 bills

Pharmacyclics Does Smart and Opportunistic Capital Raise After Huge Run Up

Pharmacyclics Inc. (NASDAQ: PCYC) has had a monster stock performance, with gains of much more than 200% over the past year. Now the company is doing what some shareholders will ...
Read Full Story »
biotech

ETF Folly: Biotech ETFs, Nothing but Confusion

24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the sector performed ...
Read Full Story »